Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed PH Specifications
- Products
-
- Diclofenac Sodium Topical Gel
- Company
- Cipla USA, Inc.
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- 92,376 tubes
- About this recall
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39